Alexis E. Te, M.D.

Urology

Publications

Peer Review Publications:

 

1.         Te AE, Colombel M, Koo HP, Kaplan SA, Buttyan R, Olsson CA, Shabsigh R. Castration-Induced Apoptosis in the Rat Penis. Surgical Forum 1992; 48: 724-725.

2.         Te AE, Koo HP, Kaplan SA, Buttyan R, Olsson CA, Shabsigh R. Neurotrophic Factors in the Diabetic Rat Penis. Surgical Forum 1993: 49: 758-760.

3.         Kaplan SA, Te AE & Jacobs BZ. Urodynamic evidence of vesical neck obstruction in men with " chronic non-bacterial " prostatitis and the therapeutic role of the endoscopic incision of the bladder neck. J Urol. 1995; 152:2063-2065.

4.         Te AE, Santarosa R, Buttyan R, Greene L, Koo HP, Kaplan SA, Olsson CA & Shabsigh R. Neurotrophic Factors in the Rat Penis. J Urol.1994; 152:2167-2172.

5.         Kaplan SA, Te AE. , Blaivas JG: Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995; 153:342-344.

6.         Kaplan SA, Te AE. Transurethral Electrovaporization of the Prostate (TVP): A novel method of treating men with benign prostatic hyperplasia. Urology 1995; 45: 566-573.

7.         Kaplan SA, Te AE. A comparative study of transurethral resection of the prostate using a modified electrovaporizaing loop and transurethral laser vaporization of the prostate. J. Urol. 1995; 154: 1785-90.

8.         Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index (TZI): A novel method of assessing benign prostatic hyperplasia: correlation with symptoms, uroflow and detrusor pressure. J Urol. 1995; 154: 1764-69.

9.         Bowers DL, Te A, Hibshoosh H, Sawczuk IS. Renal hemangiopericytoma. Case report and review of the literature. Urol Int. 1995;55(3):162-6.

10.       Kaplan SA, Bowers DA, Te AE, Olsson CA: Differential diagnosis of prostatism: 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy. J Urol. 1996; 155: 1305-1308.

11.       Kaplan SA, Olsson CA & Te AE: The American Urological Association symptom score in the evaluation of men with lower urinary tract symptom: At 2 years of followup, does it work?. J Urol. 155:1971-1974, 1996.

12.       Kaplan SA, Ikeguchi EF, Santarosa RP, Meade D’ Alisera P, Hendriks J, Te AE & Miller MI: Etiology of voiding dysfunction in men less than 50 years of age. Urology. 47: 836-839, 1996.

13.       Kaplan SA, Santarosa RP & Te AE: Comparison of fascial and vaginal wall slings in the management of intrinsic sphincter deficiency. Urology. 47: 885-889, 1996.

14.       McKiernan JM, Kaplan SA, Santarosa RP, Te AE, Sawczuk IS: Transurethral vaporization of bladder cancer. Urology 48(2): 207-10

15.       Te AE, Santarosa R, Kaplan SA.:Electrovaporization of the prostate: electosurgical modification of standard resection in 93 patients with benign hyperplasia. J Endourol 11(1):71-5, 1997.

16.       Kaplan SA, Santarosa RP, Te AE: Transurethral electrovaporization of the prostate: one year experience. Urology 48(6):876-81, 1996.   

17.       Kaplan SA, Santarosa RP, D’ Alisera PM, Fay BJ, Ikeguchi EF, Hendricks J, Te, AE: Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. J Urol 157(6):2234-7, 1997

18.       Kaplan SA, Reis RB, Cologna A, Suaid HJ, Martins ACP, Kohn IJ, Te AE: Intermittent alpha-blocker therapy in the treatment of men with lower urinary tract symptoms. Urology 52(1):12-16, 1998. 

19.       Kaplan SA, Te AE, Ikeguchi E, Santarosa RP: Safety and efficacy of alpha blockers in the treatment of men over the age of 80 with benign prostatic hyperplasia. Br J Urol 1997 Dec;80(6):875-9

20.       Kaplan SA, Reis RB, Staiman VB, Te AE: Is the ratio of transition zone to total prostate volume higher in African-American men than in their Caucasian or Hispanic Counterparts?. Br J Urol 1998, 82: 804-807  

21.       Kaplan SA, Reis RB, Kohn IJ, Ikeguchi EF, Laor E, Te AE, Martins ACP: Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999, 53:481-486. 

22.       Kaplan SA, Reis RB, Kohn IJ, Shabsigh R, Te AE: Combination therapy using oral alpha blockers and intracavernosal injection in men with erectile dysfunction. Urology 1998, 52(5): 739-43.

23.       Kaplan SA, Laor E, Fatal M, Te AE: Transurethral resection of the prostate versus transurethral electrovaporization of the prostate: a blinded, prospective comparative study with 1 years followup. J Urology 1998, 159(2):454-8. 

24.       Reis RB, Te AE, Cologna AJ, Suaid HJ, Kaplan SA: Interstitial Thermometry in Men Undergoing Electrovaporization of the Prostate. J Endourology 1999, 13 (1): 53-56.

25.       Kaplan SA, Stifelman M, Avillo C, Reis RB and Te AE: Detrusor contraction duration (DCD) may predict response to alpha blocker therapy for lower urinary tract symptoms. Eur Urol 2000 Mar;37(3):314-7.

26.       Kaplan SA, Te AE, Young GPH, Andrade A, Cabelin MA, Ikeguchi EF: Prospective analysis of 373 consecutive women with stress urinary incontinence treated with a vaginal wall sling: the Columbia- Cornell university experience, J Urol. 2000 Nov;164(5):1623-7.

27.       Choi J, Ikeguchi EF, Lee SW, Choi HY, Te AE, Kaplan SA: Is the Higher Prevalence of Benign Prostatic Hyperplasia Related to Lower Urinary Tract Symptoms in Korean Men due to a High Transition Zone Index? Eur Urol. 2002 Jul;42(1):7-11.
28.       Te AE: A modern rationale for the use of phenoxybenzamine in urinary tract disorders
            and other conditions. Clin Ther. 2002 Jun;24(6):851-61; discussion 837.
29.       Kaplan SA, Ghafar MA, Volpe MA, Lam JS, Fromer D, Te AE. PSA response to finasteride challenge in men with a serum PSA greater than 4ng/ml and previous negative prostate biopsy: preliminary study. Urology. 2002 Sep;60(3):464-8. 

30.       Te AE: Editorial Comment: Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urol. 62(2): 264.

31.       Te AE. The development of laser prostatectomy. BJU Int. 2004 Feb;93(3):262-5. 
32.       Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol. 2004 Jan;171(1):284-8.

33.       Te AE. Editorial Comment: Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia. Urology. 2004 Nov;64(5):1003-1004.

34.       Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol. 2004 Oct;172(4 Pt 1):1404-8.

35.       Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology. 2004 Dec;64(6):1155-9. 
36.       Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receivinganticoagulants.J Endourol. 2005 Dec;19(10):1196-8. 

37.      Kaplan SA, Walmsley K, Te AE. Tolterodine extended release attenuates lower urinary tract symptoms in menwith benign prostatic hyperplasia. J Urol. 2005 Dec;174(6):2273-5.

38.       González RR, Fong T, Belmar N, Saban M, Felsen D, Te AE. Modulating bladder neuroinflammation: RDP58, a novel anti-inflammatory peptide, reduces inflammation and nerve growth factor production in experimental cystitis. J Urol 2005 Feb; 173(2): 630-4.

39.       Lee R, Gonzalez RR, Te AE. The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia. World J Urol. 2006 Sep;24(4):405-9.
40.       Staskin DR, Te AE. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence. BJU Int. 2006 Jun;97(6):1256-61. 
41.       Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int. 2006 Jun;97(6):1229-33. 
42.       Monoski MA, Gonzalez RR, Sandhu JS, Reddy B, Te AE. Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention. Urology. 2006 Aug;68(2):312-7. 

43.       El-Hakim A, Leung RA, Richstone L, Kim TS, Te AE, Tewari AK. Athermal Robotic Technique of prostatectomy in patients with large prostate glands (>75 g): technique and initial results. BJU Int. 2006 Jul;98(1):47-9.

44.       Kaplan SA, Gonzalez RR, Te AE. Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction. Eur Urol. . Eur Urol. 2007 Jun;51(6):1717-23.

45.       Te AE. Current state of the art photoselective vaporization prostatectomy: laser

            therapy for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2007 Mar;10 Suppl 1:S2-5.  

46.       Lemack GE, Amundsen C, Badlani G, Griebling T, Peters K, Rodriguez L, Singla

            A, Smith C, Sullivan M, Te A. Highlights from the combined Society of Urodynamics and Female Urology, and International Society of Pelvic Neuromodulation annual meeting. J Urol. 2007 Feb;177(2):691-5.

47.       Te AE. Editorial Comment on the Manuscript, "Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: A prospective randomized multicenter study”, Urol.2007 Jan; 69(1): 96-97

48.       Te AE. Is transurethral microwave thermotherapy comparable to transurethral resection for BPH? Nat Clin Pract Urol. 2007 Sep;4(9):478-9. Epub 2007 Jul 31.

49.       Tewari AK, Bigelow K, Rao S, Takenaka A, El-Tabi N, Te A, Vaughan ED. Anatomic restoration technique of continence mechanism and preservation of puboprostatic collar: a novel modification to achieve early urinary continence in men undergoing robotic prostatectomy. Urology. 2007 Apr;69(4):726-31.

50.       Te AE. Current state of the art photoselective vaporization prostatectomy: laser therapy for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2007 Mar;10 Suppl 1:S2-5. 

51.       Lee R, Saini R, Zoltan E, Te AE. Photoselective vaporization of the prostate using a laser high performance system in the canine model. J Urol. 2008 Oct;180(4):1551-3. Epub 2008 Aug 16.

52.       Te AE. Should vardenafil be used for the treatment of lower urinary tract symptoms associated with BPH?. Nat Clin Pract Urol. 2008 Oct;5(10):536-7. Epub 2008 Aug 19.

53.       Saini R, Gonzalez RR, Te AE. Chronic pelvic pain syndrome and the overactive

            bladder: the inflammatory link. Curr Urol Rep. 2008 Jul;9(4):314-9.

54.       O'Leary MP, Wei JT, Roehrborn CG, Miner M, BPH Registry and Patient Survey Steering Committee (Te AE). Correlation of the International Prostate Symptom Score

            bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting. BJU Int. 2008 Jun;101(12):1531-5. Epub 2008 Apr 28.

55.       Kaplan SA, Walmsley K, Te AE. Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol. 2008 May;179(5 Suppl):S82-5.

56.       Schwartz MJ, Hwang DH, Hung AJ, Han J, McClain JW, Shemtov MM, Te AE, Sosa RE, Vaughan ED Jr, Scherr DS. Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy. Cancer. 2008 Apr 15;112(8):1718-25.

57.       Tewari A, Jhaveri J, Rao S, Yadav R, Bartsch G, Te A, Ioffe E, Pineda M, Mudaliar S, Nguyen L, Libertino J, Vaughan D. Total reconstruction of the vesico-urethral junction. BJU Int. 2008 Apr;101(7):871-7.

58.       Lee R, Te AE, Kaplan SA, Sandhu JS. Temporal trends in adoption of and indications for the artificial urinary sphincter. J Urol. 2009 Jun;181(6):2622-7. Epub 2009 Apr 16.

59.       Rosen RC, Wei JT, Althof SE, Seftel AD, Miner M, Perelman MA; BPH Registry and

            Patient Survey Steering Committee (Te AE). Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH

            Registry. Urology. 2009 Mar;73(3):562-6. Epub 2009 Jan 23.

60.       Tan GY, El Douaihy Y, Te AE, Tewari AK. Scientific and technical advances in continence recovery following radical prostatectomy. Expert Rev Med Devices. 2009

            Jul;6(4):431-453

 

 

Invited Review Publications:

 

1.         Kaplan SA, Te AE: Uroflowmetry & Urodynamics.Urologic Clinics of North America 1995; 22: 309-20.

2.         Te AE , Kaplan SA: Transurethral Electrovaporization of the Prostate (TVP): A electrosurgical advancement of the standard TURP. Current Surgical Techniques in Urology 1995; 8:1-9.

3.         Te AE , Reis R, Kaplan SA: Transurethral Electrovaporization of the Prostate (TVP): A novel modification of the standard TURP. Contemporary Urology 1995; 7:74-83.

4.         Te AE, Kaplan SA: Electrovaporization of the Prostate. Current Opinion in Urology 1996; 6: 2-9.

5.         Santarosa RP, Te AE, Kaplan SA: Minimally Invasive Procedures for Benign Prostatic Hyperplasia. Mediguide to Urology 1996; 9:1-6

6.         Te AE, Kaplan SA: Transurethral electrovaporization of the Prostate.Mayo Clin Proc 1998 Jul;73(7):691-5

7.         Te AE and Kaplan SA: Transurethral electrovaporization of the prostate: the year in review. Current Opinion in Urology 1997; 7:25-36. 

8.         Santarosa RP, Te AE and Kaplan SA: Minimally invasive procedures for benign prostatic hyperplasia: electrovaporization, lasers, heat therapy and stents. In: Mediguide for Urology. Ed: Carson CC. 1996; 9:1-6.

9.         Choi J, Ikeguchi EF, Te AE, Kaplan SA: Review of laser prostatectomy. Urology Review, July, 1999.

10.       Cabelin MC, Te AE, Kaplan SA: Benign prostatic hyperplasia: challenges for the new millennium.Curr Opin Urol. 2000 Jul;10(4):301-6.

11.       Cabelin MC, Te AE, Kaplan SA: Transurethral vaporization of the prostate: Current Techniques. Current Urology Reports July 2000 1(2):116-123.

12.       Kohn I, Te AE, Kaplan SA: Neuromodulations. AUA Updates; 2003.

13.       Gonzalez R, Te AE: How do transurethral needle ablation of the prostate and treansurethral microwave thermotherapy compare with transurethral prostatectomy. Current Urology Reports. August 2003. 4(4): 297-306.

14.      Gonzalez RR, Te AE. Overactive bladder and men: indications for anticholinergics. Curr Urol Rep. 2003 Dec;4(6):429-35. 

15.      Sandhu J, Te AE. The Role of 5 AR Inhibition as Monotherapy in View of the MTOPS Data. Current Prostate Reports. Volume 2, Issue 1; 2004.

16.       Gonzalez RR, Te AE. Chronic prostatitis and sensory urgency: whose pain is it? Curr Urol Rep. 2004 Dec;5(6):437-41.

17.       Yang J, Te AE. Saw Palmetto and Finasteride in the Treatment of Category-III Prostatitis/Chronic Pelvic Pain Syndrome. Curr Urol Rep. 2005 Jul;6(4):290-5. 

18.      Jaffe WI, Te AE. Overactive bladder in the male patient: epidemiology, etiology, evaluation, and treatment. Curr Urol Rep. 2005 Nov;6(6):410-8.

19.       Reddy BN, González RR, Te AE. The implications of cytokines in chronic prostatitis and chronic pelvic pain syndrome. Curr Prostate Rep Nov 2005; 3(4): 189-94.

20.       Gonzalez RR, Te AE.   Is there a role for urodynamics in chronic nonbacterial prostatitis? Curr Urol Rep. 2006 Jul;7(4):335-8. 

21.       Ng CK, Gonzalez RR, Te AE. Refractory overactive bladder in men: update on novel therapies.Curr Urol Rep. 2006 Nov;7(6):456-61.

22.       Te AE. The Next Generation in Laser Treatments and the Role of the GreenLight

            High-Performance System Laser. Rev Urol. 2006;8 Suppl 3:S24-30.

23.       Lebed, BD, Jafee WI, Te AE. Sexual Complications of Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia. Current Sexual Health Reports 2006, 3:76-82

24.       Te, AE, Laser Prostatectomy Advance for the Prostate, Renal & Urology News, May 2006, pg 27

25.       Lee R, Saini R, Kaplan SA, Te AE. A Review of Transurethral Microwave Thermotherapy. AUA Update Series. Volume 26 Lesson 28 Page 277-284

26.       Te AE. The PVP procedure for BPH: Long-term outcomes. Urology Times. January 1, 2007 Issue.

 

 

Review Publications:

 

1.         Te, AE: Literature Alerts, Current Urology Reports Volume 1, Issue 1; 2000

2.         Te, AE: Literature Alerts, Current Urology Reports Volume 1, Issue 2; 2000

3.         Te, AE: Literature Alerts, Current Urology Reports Volume 1, Issue 3; 2000

4.         Te, AE: Literature Alerts, Current Urology Reports Volume 1, Issue 4; 2000

5          Te, AE: Literature Alerts, Current Urology Reports Volume 2, Issue 1; 2001

6.         Te, AE: Literature Alerts, Current Urology Reports Volume 2, Issue 2; 2001

7.         Te, AE: Literature Alerts, Current Urology Reports Volume 2, Issue 3; 2001

8.         Te, AE: Literature Alerts, Current Urology Reports Volume 2, Issue 4; 2001

9.         Te, AE: Literature Alerts, Current Urology Reports Volume 2, Issue 5; 2001

10.       Te, AE: Literature Alerts, Current Urology Reports Volume 2, Issue 6; 2001

11.       Sandhu J, Te AE: Web Alerts, Current Urology Reports Volume 2, Issue 5; 2002

12.       Sandhu J, Te AE: Web Alerts, Current Urology Reports Volume 2, Issue 6; 2002

13.       Te, AE: Literature Alerts, Current Urology Reports Volume 3, Issue 1; 2002

14.       Te, AE: Literature Alerts, Current Urology Reports Volume 3, Issue 2; 2002

15.       Te, AE: Literature Alerts, Current Urology Reports Volume 3, Issue 3; 2002

16.       Te, AE: Literature Alerts, Current Urology Reports Volume 3, Issue 4; 2002

17.       Te, AE: Literature Alerts, Current Urology Reports Volume 3, Issue 5; 2002

18.       Te, AE: Literature Alerts, Current Urology Reports Volume 3, Issue 6; 2002

19.       Sandhu J, Te AE: Web Alerts, Current Urology Reports Volume 3, Issue 1; 2002

20.       Sandhu J, Te AE: Web Alerts, Current Urology Reports Volume 3, Issue 2; 2002

21.       Sandhu J, Te AE: Web Alerts, Current Urology Reports Volume 3, Issue 3; 2002

22.       Sandhu J, Te AE: Web Alerts, Current Urology Reports Volume 3, Issue 4; 2002

23.       Sandhu J, Te AE: Web Alerts, Current Urology Reports Volume 3, Issue 5; 2002

24.       Sandhu J, Te AE: Web Alerts, Current Urology Reports Volume 3, Issue 6; 2002

25.       Te, AE: Literature Alerts, Current Urology Reports, Volume 4, Issue 1; 2003

26.       Te, AE: Literature Alerts, Current Urology Reports, Volume 4, Issue 2; 2003

27.       Te, AE: Literature Alerts, Current Urology Reports, Volume 4, Issue 3; 2003

28.       Te, AE: Literature Alerts, Current Urology Reports, Volume 4, Issue 4; 2003

29.       Te, AE: Literature Alerts, Current Urology Reports, Volume 4, Issue 5; 2003

30.       Te, AE: Literature Alerts, Current Urology Reports, Volume 4, Issue 6; 2003

31.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 4, Issue 1; 2003

32.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 4, Issue 2; 2003

33.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 4, Issue 3; 2003

34.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 4, Issue 4; 2003

35.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 4, Issue 5; 2003

36.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 4, Issue 6; 2003

37.       Te, AE: Literature Alerts, Current Urology Reports, Volume 5, Issue 1; 2004

38.       Te, AE: Literature Alerts, Current Urology Reports, Volume 5, Issue 2; 2004

39       Te, AE: Literature Alerts, Current Urology Reports, Volume 5, Issue 3; 2004

40.       Te, AE: Literature Alerts, Current Urology Reports, Volume 5, Issue 4; 2004

41.       Te, AE: Literature Alerts, Current Urology Reports, Volume 5, Issue 5; 2004

42.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 5, Issue 1; 2004

43.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 5, Issue 2; 2004

44.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 5, Issue 3; 2004

45.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 5, Issue 4; 2004

46.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 5, Issue 5; 2004

47.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 6, Issue 1; 2005

48.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 6, Issue 2; 2005

49.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 6, Issue 3; 2005

50.       Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 6, Issue 4; 2005

51.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 6, Issue 5; 2005

52.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 6, Issue 6; 2005

53.       Sandhu J, Te AE: Web Alerts, Current Prostate Reports, Volume 3, Issue 1; 2005

54.       Sandhu J, Te AE: Web Alerts, Current Prostate Reports, Volume 3, Issue 2; 2005

55.       Sandhu J, Te AE: Web Alerts, Current Prostate Reports, Volume 3, Issue 3; 2005

56.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 3, Issue 4; 2005

57.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 7, Issue 1; 2006

48.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 7, Issue 2; 2006

49.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 7, Issue 3; 2006

50.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 7, Issue 4; 2006

51.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 7, Issue 5; 2006

52.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 7, Issue 6; 2006

53.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 4, Issue 1; 2006

54.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 4, Issue 2; 2006

55.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 4, Issue 3; 2006

56.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 4, Issue 4; 2006

57.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 8, Issue 1; 2007

58.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 8, Issue 2; 2007

59.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 8, Issue 3; 2007

60.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 8, Issue 4; 2007

61.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 8, Issue 5; 2007

62.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 8, Issue 6; 2007

63.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 5, Issue 1; 2007

64.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 5, Issue 2; 2007

65.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 5, Issue 3; 2007

66.       Ng C, Te AE: Web Alerts, Current Prostate Reports,Volume 5, Issue 4; 2007

67.       Winfield HN, Tally GG, Wong MYC, Te AE, Assimos DG, Conlin M, Duchene DA, Cadeddu JA, Hemal A. Journal of Endourology. June 2007, 21(6): 563-573

68.       Winfield HN, Tally GG, Wong MYC, Te AE, Assimos DG, Conlin M, Duchene DA, Cadeddu JA, Hemal A. Survey of Endourology 2007 J Endourology 21(11): 1235-1248

69.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 9, Issue 1; 2008

70.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 9, Issue 2; 2008

71.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 9, Issue 3; 2008

71.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 9, Issue 4; 2008

73.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 9, Issue 5; 2008

74.       Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 9, Issue 6; 2008

75.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 6, Issue 1; 2008

76.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 6, Issue 2; 2008

77.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 6, Issue 3; 2008

78.       Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 6, Issue 4; 2008

79.       Winfield HN, Tally GG, Wong MYC, Te AE, Assimos DG, Conlin M, Duchene DA, Cadeddu JA, Hemal A. Survey of Endourology 2008 J Endourology 22 (11): 2415-2428

80.       Winfield HN, Tally GG, Wong MYC, Te AE, Assimos DG, Conlin M, Duchene DA, Cadeddu JA, Hemal A. Survey of Endourology 2008 J Endourology August 2008, 22(8): 1597-1608

81.       G.G. Tailly, H.N. Winfield, M.Y.C. Wong, A.E. Te, D.G. Assimos, M.J. Conlin, D.A. Duchenne, J.A. Cadeddu, A.K. Hemal. Survey of Endourology 2008 J Endourology 22(5): 847-858.

82.      G.G. Tailly, H.N. Winfield, M.Y.C. Wong, A.E. Te, D.G. Assimos, M.J. Conlin, D.A. Duchenne, J.A. Cadeddu, A.K. Hemal. Survey of Endourology. J Endourology. February 2009: 23(2): 209-222.

83.      G.G. Tailly, H.N. Winfield, M.Y.C. Wong, A.E. Te, D.G. Assimos, M.J. Conlin, D.A. Duchenne, J.A. Cadeddu, A.K. Hemal. Survey of Endourology. J Endourology. June 2009, 23(6): 879-890

 

 

Book Chapters:

 

1.         Kaplan SA, Te AE: Bladder Dysfunction in Diabetes, In: Paulson, ed. Problems in         Urology; Neurourology and its Role in Urologic Diseases: Part I. Philadephia: J. B. Lippincott Co., 6: 659-668. 1992.

2.         Te AE , Kaplan SA: Pharmaceutical Treatment of BPH and its effect on indications for    prostate surgery.  In: Surgical Technology International III: Endourology. San Francisco:       Universal Medical Press, Inc.1994.

3.         Te AE, Kaplan SA: Urodynamics and BPH. In: Kirby RS, McConnell JD, Fitzpatrick      JM, Roehrborn CG, Boyle P, eds. Textbook of Benign Prostatic Hyperplasia. Oxford: Isis             Medical Media, LTD., 187-198. 1996.

4.         Te AE, Kaplan SA: Prostatic Endoprosthetics. In: Kirby RS, McConnell JD, Fitzpatrick  JM, Roehrborn CG, Boyle P, eds. Textbook of Benign Prostatic Hyperplasia. Oxford: Isis             Medical Media, LTD. 453-462.1996.           

5.         Te AE, Kaplan SA: Electrovaporization of the Prostate: Advance Application of  Electrosurgical Principles to the Treatment of Benign Prostatic Hyperplasia. In: Kirby             RS, O’Leary MP, ed. Recent Advances in Urology 7. London: Churchill Livingston,     1998.

6.         Santarosa RP, Te AE, Kaplan SA: Transurethral resection, incision and ablation of the      prostate. In: Graham SD, ed. Glenn’s Urologic Surgery, 5th edition. Philadephia: Lippincott,     Williams and Wilkins. 921-931.1998.

7.         Te AE, Santarosa RP, Kaplan SA: Tranurethral Electrovaporization of the Prostate. In:     Resnick MI, Thompson IM, ed. Surgery of the Prostate. London: Churchill Livingston.295-      307. 1998.

8.         Te AE, Kaplan SA: Electrovaporization Principles. In: Narayan P, ed. Benign Prostatic     Hyperplasia. London: Churchill Livingstone, 325-334. 2000.

9.         Kohn IJ, Te AE and Kaplan SA: Urodynamics of prostatitis. In: Nickel JC ed., Textbook of        prostatitis. Oxford: Isis Medical Media, LTD. 2000.

10.       Ikeguchi EF, Te AE, Choi J, Kaplan SA: Bladder Outlet Obstruction in Males. In: Appel             RA,ed. Current Clinical Urology: Diagnosis and Treatment. Totowa, NJ: Humana Press Inc.          2000. 

11.       Te AE, Ikeguchi EF, Kaplan SA: Transurethral Electrovaporization of the Prostate. In:                   

            Recent Advances in Endourology. Vol. 2/ Treatment of BPH. Tokyo: Springer-Verlag. 157- 166, 2000.

12.       Te AE, Kaplan SA: Complication of Minimally Invasive Surgery for BPH. In: Taneja       SS, Smith RB, Ehrlich RM, ed. Complication of Urologic Surgery, 3rd edition.      Philadelphia: W. B. Saunders, 244-256, 2001.            

13.       Cabelin M, Te AE and Kaplan SA: Urogenital physiology. In: Gonzalez, Myers, Edelman,         Leiberman and Downey, ed., Physiological Basis of Rehabilitation Medicine.191-208, 2001. 

14.       Te AE, Kaplan SA: Electrovaporization of the Prostate. In: Miller PD, Eardley I,Kaplan SA, ed. Benign Prostatic Hyperplasia: Laser and Heat Therapy.. London: Martin Dunitz. 2001.

15.       Volpe M, Ghafar MA, Te AE: Diagnosis and Management of Obstruction after Anti-Incontinence Surgery. In: Carlin BI and Leong FC, ed. Female Pelvic Health and Reconstructive Surgery. New York, NY: Marcel Dekker, Inc. 2002.

16.       Sandhu JS, Te AE: Open Prostatectomy. In: Kaplan SA and Cabelin M, ed. Atlas of Urologic Clinics of North America. Philadelphia, PA: W. B. Saunders. April 2002.

17.       Cabelin MA, Ghafer MA, Te AE, Kaplan SA: Transurethral Vaporization of the Prostate. In: Kaplan SA and Cabelin M, ed. Atlas of Urologic Clinics of North America. Philadelphia, PA: W. B. Saunders. 45-49, 2002.

18.       Sandhu J, Te AE. Benign Prostatic Hyperplasia (BPH). In: Martini L, ed. Encyclopedia of Endocrine Diseases: 4 Volumes. San Diego, Ca. Academic Press 2004

19.       Te AE, Ikeguchi EF, Choi J, Kaplan SA: Urodynamics and benign prostatic hyperplasia. In: Kirby RS, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P., ed. Textbook of benign prostatic hyperplasia. 2nd Edition. Oxford: Isis Medical Media Ltd. 2005, pg 241-253.

20.       Hyman MJ, Te AE: Stents, TUIP and Electrovaporization. In: Kaplan SA, Atala A and Partin A, ed. Minimally Invasive Alternatives in Urology. New York, NY: Marcel Dekker, Inc. 2005.

21.       Gonzalez RR, Lee R, Sandhu JS, Te AE. Laser Prostatectomy   In Atlas of the Prostate, Eds. Scardino PT, Slawin K. 3rd Edition, 2006.

22.       21.       Gonzalez RR, Tyagi T, Te AE. Neurologic Disorders. In: Cardozo L and Staskin D, Ed. Textbook of Female Urology and Gynecology.United Kingdom. 2006. pg 565-582.

23.       Schiff JD, Te AE. Electrosurgery of the Prostate: Improvements in TURP-Treatment and Outcomes. In: Smith AD et al, Ed. Smiths’ Textbook of Endourology. 2nd Edition 2007. pg.645-651

24.       Lee R, Sandhu J, Gonzalez RR, Te AE. Laser Prostatectomy. In: Smith AD et al, Ed. Smiths’ Textbook of Endourology. 2nd Edition 2007. pg. 617- 626.

25.       25.       Te AE. Benign Prostatic Hyperplasia. In: Morey A. Shokes DA, Ed. The American Urological Association Educational Review Manual in Urology. 1st Edition 2007.

26.       Ulchaker JC, Te AE. Benign Prostatic Hyperplasia. In: Morey A. Shokes DA, Ed. The American Urological Association Educational Review Manual in Urology. 2nd Edition 2009.

 

 

 

 

Multimedia Publications:

 

1.         Te AE, Kaplan SA: Transurethral electrovaporization of the prostate. Endourology on CD-ROM. Vol. 1, Editors; Paoletti P & Benelli R, IPE Mutimedia, Firenze, Italty.1997.

2.         Te AE, Ghafar MA, Merriweather T, Volpe MA, Ikeguchi E, Kaplan SA. Nomogram and urodynamic predictors of urinary retention in men with BPH and Bladder Outlet Obstruction. Poster #1096.Annual AUA Meeting 2001 CD ROM of Top 120 Poster Presentation.

3.         Kaplan SA, Blute M, Bruskewitz RC, Te AE, Larson TR, Utz W, Ugarte R, Mayer R: Long term efficacyand durability in 345 patients treated with transurethral microwave thermotherapy for benign prostatic hyperplasia: five year results. Poster #1153 .Annual AUA Meeting 2002 CD ROM of Top 120 Poster Presentation.

4.         González RR, Te AE. Photoselective vaporization of the prostate with the 80 watt quasicontinuous KTP laser for the treatment of benign prostatic hyperplasia. DVD Video. American College of Surgeons, Cine Clinics, Clinical Congress, October 12, 2004, New Orleans, LA CC I: Urological surgery CD Collection Cat Number VS1090.

5.         Sandhu JS, Te AE, Eilber KS. The Male Bulbourethral Sling. Society for Female Urology and Urodynamics. SUFU Annual Meeting, Grand Bahamas. Best Video Award. 2005

6.         Sandhu JS, Te AE. Photoselective Vaporization of the Prostate - The Vaporization Incision Technique for Large Volume Prostates. AUA Annual Meeting. 2005 J Urol 2005, 173(4): 366.

7.         Te AE, Gonzalez R, Sandhu JS Photoselective Vaporization of the Prostate - The Vaporization Incision Technique (PVP-VIT) in DVD titled, Il Laser Per Il Trattamento Dell’Iperplasia Prostatica Benigna, Editor, Roberto Benelli, Italy, 2005.

8. .       Te AE Laser Prostatectomy for the Treatment of BPH Q & A from Prostatic Hyperplasia (BPH) 2006: Are We Treating a New Disease? In Topics in Urology Audio Series. Moderator: P Rogers. Oakstone Medical Publishing. CME Accredited Series.  Fall 2006.

9.         Te AE. Urodynamics and BPH slide set. Timely Topics in Medicine. Prious Sceince. www.ttmed.com.12/12/07

10.       Te AE. Urodynamcis and BPH article. Timely Topics in Medicine. Prious Sceince. www.ttmed.com.12/12/07

 

 

Abstracts:

 

1.         Te AE, Buttyan R, Koo HP, Greene LA, Kaplan SA, Olsson CA & Shabsigh R: Abundant expression of nerve growth factor (NGF) in the rat penis, a developmental study. J Urol. 147:239A, 1992.

2.         Te AE, Buttyan R, Koo HP, Shabsigh R, Olsson CA & Kaplan SA: Nerve growth factor in diabetic cystopathy. J Urol. 147:350A, 1992.       

3.         Koo HP, Buttyan R, Te AE, Kaplan SA, Olsson CA & Shabsigh R: Neurotrophin expression in diabetic rat penis: a new insight into pathogenesis of erectile dysfunction. J Urol. 147:240A, 1992.

4.         Shabsigh R, Buttyan R, Koo HP, Kaplan SA, Olsson CA & Te AE: Expression of neurotrophins: nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) in the rat penis. J Urol. 147:318A, 1992.

5.         Brown W, Te AE, Olsson CA & Benson MC: Management of complications of continent urinary diversions. J Urol. 147:390A, 1992.

6.         Te AE, Buttyan R, Koo HP, Olsson CA & Kaplan SA: Nerve growth factors in diabetic cystopathy. Neurourology and Urodynamics. 11(4):303, 1992.

7.         Te AE, Buttyan R, Koo HP, Shabsigh R, Olsson CA & Kaplan SA: Nerve growth factors in diabetic cytopathy. Diabetes. 41(Sup 1):140A, 1992.

8.         Kaplan SA, Te AE & Blaivas JG: Urodynamic findings in patients with diabetes and voiding symptoms: surprising results. International Continence Society. 22nd Ann. Mtg. Abstract 115, 1992.

9.         Te AE, Buttyan R, Koo HP, Kaplan SA, Olsson CA & Shabsigh R: Neurotrophic Factors in the diabetic rat penis: an extended study. J Urol. 149:247A, 1993.           

10.       Santarosa RP, Te AE, Koo HP, Buttyan R, Kaplan SA, Olsson CA & Shabsigh R: Androgen Deprivation and Apoptosis in Rat Erectile Tissue. J Urol. 151:494A, 1994.

11.       Te AE, Olsson CA & Kaplan SA: Use of the AUA-BPH treatment guidelines in men with symptomatic benign prostatic hyperplasia (BPH): At one year, is it effective?. J Urol. 151:507A, 1994.

12.       Shabsigh R, Te AE, Koo HP, Kaplan SA, Olsson CA & Shabsigh: Localization of nerve growth factor beta (NGF) in the rat penis by in-situ hybridization. Society for Basic Urologic Research Fall Symposium, Rochester, MN, 1991.

13.       Te AE, Colombel M, Koo HP, Kaplan SA, Buttyan R, Olsson CA & Shabigh R: Castration- induced apoptosis in the rat penis. ACS Annual Mtg. Chicago Il, 1992.

14.       Shabsigh R, Te AE & Fisch H: Cavernous electromyography as an indication of adequate smooth muscle relaxation during duplex ultrasonography. 5th World Meeting on Impotence. Milan, Italy, 1992.

15.       Te AE, Buttyan R, Koo HP, Greene L, Kaplan SA, Olsson CA & Shabsigh R: Neurotrophins in the rat penis. 5th World Meeting on Impotence. Milan, Italy, 1992.

16.       Santarosa RP, Te AE, Koo HP, Raymond J, Columbel M, Olsson CA, Buttyan R & Shabsigh R: Testoterone sensitivity of the erectile tissue of the rat penis to castration. 7th World Meeting on Impotence. Singapore, ISIR, 1994.

17.       Te AE, Kaplan SA, Dann JA. Transurethral electrovaporization of the prostate (TVP): A novel method for treating men with benign prostatic hyperplasia. J Urol. 1995; 153: 436A.

18.       Te AE, Santarosa R, Kaplan SA. Transurethral electrovaporization of prostate (TVP): A modification on the standard TURP. J Endourology 1995; 9: S58.

19.       Kaplan SA, Santarosa RP, Te AE: Electrovaporization of the prostate for symptomatic benign prostatic hyperplasia: the 1 year experience. J Urol. 1996, 155(5):405A.

20.       Reis RB, Cologna AJ, Suaid HJ, Kaplan SA, Te AE: Electrovaporzation of the prostate (VAP): a comparison of roller electrode configurations for resecting prostate tissue. J Urol. 1996, 155(5):406A.

21.       Laor E, Kaplan SA, Te AE, Tolia BM and Reid RE: Laser vaporization of ‘large” prostate glands: long term     follow - up. J Urol. 1996, 155(5):706A.

22.                                                       Reis RB, Cologna AJ, Suaid HJ, Te AE and Kaplan SA: Interstitial thermometry in men undergoingelectrovaporization: is it safe? J Urol. 1996, 155(5):707A.

23.       Kaplan SA, Santarosa RP, Te AE: The incidence of hypertension in men with benign prostatic hyperplasia. XIIth European Urology Association, Paris, 1996.

24.       Kaplan SA, Laor E, Te AE: Transurethral rsection of the prostate (TURP) versus  electrovaporization of the prostate (VAP): a prospective, blinded comparative study of           the treatment of benign prostatic hyperplasia (BPH). XXIIth European Urology     Association, Paris, 1996.

25.       Avillo C, Stifelman M, Te AE, Sandler P and Kaplan SA: The urodynamic parameter: detrusor contraction duration (DCD) predicts response to alpha blocker therapy for lower urinary tract symptoms (LUTS). J Urol.1997, 157(4): 136.

26.       Te AE, Laor EL, Kaplan SA, Babayan R, Noble M, Mbust W, Bruskewitz R, Whitfield HN: Transurethral resection of the prostate (TURP) versus vaporization of the prostate utilizing a vaporizing loop (TVLOOP): a multicenter, blinded, prospectie comparative study. J Urol.1997, 157(4): 313.

27.       Te AE, Laor E, and Kaplan SA: Transurethral resection of the prostate (TURP) versus transurethral electrovaporization of the prostate (TVP): a blinded, prospective comparative study with 1 year follow - up. J Urol.1997, 157(4): 313. 

28.       Pressler LB, Santarosa RP, Te AE and Kaplan SA: The incidence of hypertension (HTN) in a population of men with benign prostatic hyperplasia (BPH): analysis based on the AUA symptom score and race. J Urol.1997, 157(4): 371.

29.       D’Alisera PM, Stifelman M, Kohn I, Te AE, Weiner DM, Kaplan SA: Correlation of lower urinary tract symptom (LUTS) severity by International Prostate Symptom Score (IPSS) and erectile dysfunction (ED) in men over 50 years of age. J Urol. 1998, 159(5): 103.

30.       Reis RB, Suaid HJ, Cologna AJ, Te AE, Kaplan SA: Men with lower urinary tract symptoms (LUTS) and inguinal hernias (HERN) have significantly greater bladder outlet obstruction (BOO) than men with LUTS alone. J Urol. 1998, 159(5): 139.

31.       Reis RB, Suaid HJ, Cologna A, Martins ACP, Te AE, Kaplan SA: Intermittent therapy with alpha blocker, alfuzosin. J Urol. 1998, 159(5): 331.

32.       Nejat RJ, Ikeguchi EF, Te AE, Reis RB, Kaplan SA: Electrovaporization of the prostate utilizing the roller ball and/or vaporizing loop for the symptomatic benign prostatic hyperplasia (BPH): The 4- year Columbia experience. J Urol 1999, 161(4): 391.

33.       Ries RB, Martins ACP, Cologna A, Junior ST, Te AE, Kaplan SA: Long term durability of intermittent alpha blockade in the treatment of lower urinary tract symptoms (LUTS). J Urol 2000, 163(4): 1362.

34.       Choi J, Ikeguchi EF, Lee SW, Choi HY, Te AE, Kaplan SA: Characterization of lower urinary tract symptoms and prostate parameters in Asian men compared to Caucasians, Hispanics and African - Americans. J Urol 2000, 163(4): 1110, 250.

35.       Cabelin MA, Te AE, Ikeguchi EF, Andrade AJ, Young GPH, Kaplan SA: Prospective analysis of 327 women with stress urinary incontinence treated with vaginal wall sling: a multicenter experience. Neurourology & Urodynamics 2000, 19(3):323-364.

36.       Cabelin MA, Hyun G, Te AE, Meade D’Alisera P, Shabsigh R, Kaplan SA. Increased incidence of depressive symptoms in women with stress urinary incontinence. Neurourology & Urodynamics 2000, 19(3):323-364.

37.       Volpe MA, Te AE, Kaplan SA. A prospective trial using saw palmetto versus finasteride in the treatment of chronic nonbacterial prostatitis. J Urol 2001, 165(5): 27.

39.       Te AE, Ghafar MA, Merriweather T, Volpe MA, Ikeguchi E, Kaplan SA. Nomogram and urodynamic predictors of urinary retention in men with BPH and Bladder Outlet Obstruction. J Urol 2001, 165(5): 267.

40.       Cooper K, Littlejohn JO, Te AE, Kaplan SA: Disappointing long term results of transvaginal bone anchors       in the treatment of stress urinary incontinence (SUI): The 3-year New York Presbyterian hospital experience. J Urol 2002 , 167(4): 78.

41.       Rodgers JM, Te AE, Ghafar M, Kaplan SA, Zaontz MR, Packer M, Dean GE: Glibenclamide enhances stretch-activated contrationin rat bladders and shows protective effects in human diabetic cystopathy. J Urol 2002, 167 (4): 42.

42.       Kaplan SA,Te AE: Electrovaporization of the prostate utilizing the roller ball and/or vaporizing loop for symptomatic benign prostatic hyperplasia ( BPH): the 7 year Columbia experience in 650 consecutive men. J Urol 2002, 167 (4): 296.

43.       Kaplan SA,Te AE: Pressure/ flow evaluation of ethnically diverse men treated by minimally invasive surgical therapies for BPH: The New York Presbyterian Hospital Experience. J Urol 2002, 167 (4): 366.

44.       Gonzalez RR, Sher K, Fong T, Te AE: RDP58 reduces bladder inflammation in a murine model of acute inflammatory cystitis. J Urol 2003, 169 (4): 68.

45.       Gonzalex RR, Sher K, Fong T, Te AE: The effect of DMSO on bladder inflammation in a murine model of acute inflammatory cystitis. J Urol 2003, 169 (4): 69.

46.       Sandhu SS, Vanderbrink BA, Egan C, Kaplan SA, Te AE: High-power KTP photoselective laser vaporization prostatectomy for the treatment of benign prostatic hyperplasia in men with large prostates. J Urol 2003, 169(4): 393.

47.       Te AE, Malloy TR, Stein BS, Ulcahker JC, Hai MA, Nseyo UO, Malek RS: Photoselective laser vaporization of the prostate (PVP) for the treatment of benign prostatic hyperplasia: The first multicenter prospective trial. J Urol 2003, 169(4): 465.

48.       Cooper K, Te AE, Kaplan SA: Long term safety and efficacy in 147 patients treated with prostate stents for benign prostatic hyperplasia: 12 year results. J Urol 2003, 169(4):465.

49.       Sandhu SS, Vanderbrink BA, Egan C, Kaplan SA, Te AE: High-power KTP photoselective laser vaporization prostatectomy for the treatment of benign prostatic hyperplasia in men with large prostates. World Congress of Endourology, Toronto, 9/2003

50.       Kaplan, SA, Walmsley K, Te AE. Use of muscurinic receptor antagonist as monotherapy in men with lower urinary tract symptoms who failed previous therapy with alpha blockers. J. Urol. 2004 171(4):243

51.       Te AE, Kaplan SA: Dutasteride provides improvement in urodynamic parameters over 2 years: Analysis of data from the phase III dutasteride studies. J Urol. 2004 171(4): 359

52.       Malloy TR, Stein BS, Ulcahker JC, Nseyo UO, Hai MA, Malek RS, Te AE:          Photoselective laser vaporization of the prostate (PVP) for the treatment of benign         prostatic hyperplasia: 24-month results from a prospective multicenter clinical trial. J            Urol. 2004 171(4): 399.

53.       Sandhu JS, Ng CK, Gonzalez R, Kaplan SA, Te AE: High-power KTP photoselective       laser vaporization prostatectomy for the treatment of benign prostatic hyperplasia in men        with large prostate: The New York Presbyterian series of 64 patients. J Urol. 2004        171(4): 400.

54.       Te AE, Sandhu JS, Gonzalez R, Egan C, Kaplan SA, Te AE: High-power KTP      photoselective laser vaporization prostatectomy (PVP) versus transurethral          electrovaporization of the prostate (TVP) for the treatment of benign prostatic hyperplasia ( BPH): A prospective comparative trial. J Urol. 2004 171(4): 402.

55.       Okeke Z, Walmsley K, Te AE, Kaplan SA: Sexual function in ethnically diverse men with Category III Prostatitis/ Chronic Pelvic Pain Syndrome. J Urol 2004 171(4): 60.

56.       Monoski MA, Sandhu JS, González RR, Te AE. Urodynamic predictors of success with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention. J Urol 2005, 173(4): 354.

57.       Te AE, Sandhu JS, Reddy B, Ng CK, González RR, Kaplan SK. The first 200 patients treated with high power KTP photoselective laser vaporization prostatectomy: the New York Presbyterian experience.  J Urol 2005, 173(4): 423.

58.       Sandhu JS, Te AE. Electrosurgical transurethral resection of the prostate: Evaluating the training gap. J Urol 2005, 173(4): 34.

59.       Sandhu JS, Te AE. Photoselective vaporization of the prostate-The vaporization incision technique for large volume prostates.  J Urol 2005, 173(4): 366.

60.       Te AE, Malloy TR, Stein BS, Ulcahker JC, Nseyo UO, Hai MA. Impact of prostate specific antigen and prostate volume as predictors of efficacy outcomes in photoselective vaporization prostatectomy (PVP): Analysis and results of ongoing prospective multicenter study at three years. J Urol 2005, 173(4): 421.

61.       Malloy TR, Sandhu JS, Smith AL, Reddy B, Harryhill JF, Kaplan SA, Te AE. Photoselective vaporization of the prostate (PVP) in anticoagulated patients: A multicenter retrospective evaluation of feasibility. J Urol 2005, 173(4): 423.

62.       Stein BS, Te AE, Malloy TR, Ulcahker JC, Nseyo UO, Hai MA. Factors influencing efficacy outcomes in photoselective vaporization prostatectomy (PVP): Analysis and results of ongoing prospective multicenter study at three years. Urol 2005, 66(Supplement 3A):17-18

63.       Reddy B, Gonzalez RR, Sandgu JS, Kaplan SA, Te AE. High power KTP photoselective vaporization prostatectomy: The New York Presbyterian Experience. . Urol 2005, 66(Supplement 3A): 19.

64.       Kaplan SA, González RR, Ogiste J, Te AE. Combination of an alpha-blocker, alfuzosin SR and a PDE-5 inhibitor, sildenafil citrate, is superior to monotherapy in treating lower urinary tract symptoms (LUTS) and sexual dysfunction.  J Urol 2006, 175(4): 528.

65.       Kaplan SA, Kaplan JD, González RR, Te AE. The use of a voiding diary to evaluate urinary frequency and nocturia is a better indicator than the IPSS in assessing alpha-blocker efficacy in men with lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH).  J Urol 2006, 175(4): 438.

66.       González RR, Reddy B, Chen J, Staskin DR, Te AE. Effects of short-term estrogen deprivation on experimental bladder inflammation. J Urol 2006, 175(4): 61-2.

67.      Penson D, Litwin MS, Payne R, Te AE, Metzger C, Wei JT Do Socioeconomic Characteristics Play a Role in Treatment Choice for BPH? J Urol 2006, 175(4): 2.

68.       Monoski MA, Gonzalez RR, Sandhu JS, Reddy B, Te AE. Urodynamic predictors of outcomes with photoselective laser vaporizationprostatectomy in patients with benign prostatic hyperplasia and preoperative retention. 2006 SUFU Annual Meeting . Grand Bahamas 2006 February

69.       Ricardo R. Gonzalez, Balaji N. Reddy, Jaspreet S. Sandhu, Steven A. Kaplan, and Alexis E. Te, High-power KTP photoselective laser vaporization prostatectomy:

            The New York Presbyterian Experience. 2006 SUFU Annual Meeting. Grand Bahamas 2006 February.

70.       Balaji N. Reddy, R. R. Gonzalez, S. A. Kaplan, and A.E. Te, High-Power KTP
Photoselective Vaporization Prostatectomy (PVP): The Cornell Experience. American Society of Laser Medicine and Surgery Annual Meeting 2006, Boston, Massachusetts

            ASLMS. April 6, 2006

71.       Te AE, Gonzalez RR, Reddy B, and Kaplan SA. Photoselective laser vaporization prostatectomy-vaporization incision technique for large prostates. Western Section American Urological Association, Maui, HI October 22, 2006

72.       Te AE, Yang JH, Gonzalez RR, Reddy B, Xi Z, Madhu M, and Kaplan SA. Safety and efficacy of photoselective laser vaporization of the prostate for benign prostatic hyperplasia (BPH) in men over 80 years. Western Section American Urological Association, Maui, HI October 22, 2006

73.       Roehrborn CG, Penson D, Te AE, Wei JT, Nuckolls J. Why Men on Watchful Waiting for LUTS/BPH Start Medical Therapy: Findings from the USA BPH Registry & Patient Survey, Annual SIU Meeting, 2006, South Africa 11/13/06

74.       Hung AJ, Schwartz MJ, Hwang DH, McClain JW, Han J, Shmetov MM, Te AE, Sosa RE, Vaughan ED, Scherr DS. Changes in practice patterns and outcomes of transrectal ultrasound-guided biopsy. 2007 J Urol. 177(4): 203 Suppl.

75.       Roehrborn CG, Wei JT, Steers WD, Miner M, Seftel AD, Te AE, BPH Registry Steering Committee. Health-related quality of life is the main predictor of progression to benign prostatic hyperplasia related surgery: outcomes data from the BPH registry & patients survey. 2007 J Urol. 177(4): 495 Suppl. 

76.       Kaplan SA, Fisch H, Berriman SJ, Saini R, Lee R, Te AE, Central obesity as measured by waist circumference is predictive of severity of lower urinary tyract symptoms, sexual dysfunction, and componenets of the metabolic syndrome.. 2007 J Urol. 177(4): 497 Suppl

77.       Rao S, Martinez-Salamanca JI, Ramanathan R, Mandhani A, Leung R, Te AE, Berryhill R, Horninger W, Takennaka A, Vaughan ED, Tewari A. Total reconstruction technique of the continence mechanism following robotic prostatectomy. 2007 J Endourology 21 (Suppl 1): P28. 

78.       Rao S, Ramanathan R, Martinez-Salamanca JI, , Mandhani A, Te AE, Bartsch G, Tewari A. Total continence outcomes in patients undergoing robotic prostatectomy- A comparison of three techniques. 2007 J Endourology 21 (Suppl 1): P28. 

79.       Rao S, Takennaka A, Martinez-Salamanca JI, Li P, Leung R, Mandhani A, Ramanathan R, Bartsch G, Te AE, Tewari A. Total reconstruction technique of the continence mechanism following robotic prostatectomy. 2007 J Endourology 21 (Suppl 1): A229.

80.       Saini R, Te AE, Tewari AK, Rao AR, Kaplan SA. Predictive factors for post prostatectomy (RP) urinary incontinence (UI) in men with pre-operative lower urinary tract symptoms ( LUTS): a pilot study. Neurourology & Urodynamics 2007 26(7): 1105 Suppl   

81.       Lee R, Saini R, Te AE. Photoselective vaproization of hte prostate (PVP) using the Greenlight high performance system (HPS) in the canine model. Neurourology & Urodynamics 2007 26(7): 1094 Suppl.

82.       Monoski M, Te AE, Kaplan SA. Lower urinary tract symptoms associated with obstructive sleep apnea improve after treatment with continuous positive airway pressure. Neurourology & Urodynamics 2007 26(7): 1063 Suppl.

83.       Zoltan E, Lee RR, Saini R, Egan CA, Kaplan SA, Te AE. Comparative evaluation of the high power 532 nm laser systems, 120 Watt (HPS) VS 80 Watt (KTP), for photoselective vaporization of the prostate (PVP) of large glands with vaporization incision technique (VIT) J Urol. 2008 179 (4): 626 Suppl.

84.       Gonzalez RR, Soni SD, Reddy B, Madhu M, Kaplan SA, Te AE. Octogenarians with symptomatic benign prostatic hyperplasia (BPH) have similar outcomes after photoselective vaporization of the prostate (PVP) compared to a younger cohort despite increased comorbidities J Urol. 2008 179 (4): 631 Suppl.

85.       Kaplan SA, Zoltan E, Te AE. Safety and efficacy of tolterodine, solifenacin, and darifenacin in men with oower urinary tract symptoms (LUT) on alpha-blockers with persistent overactive bladder symptoms (OAB) J Urol. 2008 179 (4): 701 Suppl.

86.       Rao S, Tu J, Jhaveri J, Yadav R, Leung R, Martinez-Salamanca JI, Takenaka A, Te AE, Bartsch G, Vaughan ED, Tewari A. Distribution of peri-prosatic nerves in the fascial planes around the prostate- Implications for the technique of nerve sparing radical prostatectomy. J Urol. 2008 179 (4): 228 Suppl.

87.       Jhaveri J, Chhabra P, Te AE, Takenaka A, Tu J, Yadav R, Rao S, Leung R, Salamanca J, Bartsch G, Menon A, Vaughan ED, Tewari A. Grades of robotic nerve sparing J Urol. 2008 179 (4): 488 Suppl.

88.       Chung DE, Lee R, Te AE. Transurethal Laser Enucleation of the Prostate (TLEP) - 2-Year Experience J Urol. 2009 181 (4):130 Suppl.

89.       Tan GY, Jhaveri JK, Scott A, Dorsey PJ. Herman M, Te AE, Rao S, Tewari A. Biomechanical foundations for accelerated continence recovery after robotic-assisted radical prostatectomy J Urol. 2009 181 (4): 361 Suppl.

90.       Te AE, Chung DE, Lee RI, Kaplan SA. Near-infrared Spectroscopy (NIRS) for Application in Urology J Urol. 2009 181 (4): 601 Suppl.

91.       Lee R, Te AE, Kaplan SA, Sandhu JS. Temporal Trends in Adoption of and Indications for the Artificial Urinary Sphincter (AUS) J Urol. 2009 181 (4): 617 Suppl.

92.       Kaplan SA, Chung DE, Sandhu JS, Te AE. Generic substitutes are neither as safe nor effective as branded medications: experience in men treatred for lower urinary tract sysmptoms. J Urol. 2009 181 (4): 649 Suppl.

93.       Kaplan SA, Chung DE, Sandhu JS, Te AE. Safety and efficacy concerns in switching patients with overactive bladder (OAB) symptoms from branded to generic anticholinergic medications. J Urol. 2009 181 (4): 675 Suppl.

94.       Chung DE, Te AE, Staskin DR, Kaplan SA. Efficacy and safety of tolterodine extende J Urol. 2009 181 (4): 488 Suppl.d release and dutasteride in male overactive bladder (OAB) patients with prostates = 30 grams. J Urol. 2009 181 (4): 697 Suppl.

95.       Chung DE, Te AE, Staskin DR, Kaplan SA. Efficacy and safety of tolterodine extended release and dutasteride in male OAB patients with prostates ³ 30 grams. Neurourology Urodynamics. 2009 28 (2):161.

96.       Chung DE, Lee RK, Scofield S, Te T, Te AE. KTP laser photoselective vaporization of the prostate: 6-year experience. Neurourology Urodynamics 2009 28(2): 161.

Video Presentations and Publications:

 

1. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate. J Urol.1995; 153: 48A.

2. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate. Video Urology Times. 1995.

3. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate., WHO-BPH Meeting. 1996

4. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate., WHO-BPH Meeting. 1997

5. Te AE, Gonzalez: Photoselective Vaporziation of the Prostate with the 80 Watt Quasicontinous KTP Laser for the treatment of BPH., American College of Surgeons Annual Meeting. The 55th Cine-Clinic. 2004

6. Sandhu JS, Te AE. Photoselective vaporization of the prostate-The vaporization incision technique for large volume prostates.  J Urol 2005, 173(4): 366.

7. Chung DE, Lee R, Te AE. Transurethal Laser Enucleation of the Prostate (TLEP) - 2-Year Experience J Urol. 2009 181 (4):130

 

Back to topBack To Top